Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks to slip in early deals
(Sharecast News) - UK stocks are expected to edge lower on Monday, following a mixed performance on Asian indices overnight, London's FTSE 100 was falling 0.4% in pre-market trade from Fridays close of 7,683.91.
Ongoing concerns about China's property sector were likely weighing on sentiment early on, after struggling Chinese developer China Evergrande scrapped a $35bn debt-restructuring plan, causing shares to drop 19% in Hong Kong. The Hang Seng Index fell 1.7%, but the Shanghai Composite declined just 0.6% while the Nikkei gained 0.9%.
Investors will likely be keeping a close eye on the price of oil again as it climbs further above the $90-a-barrel mark. Brent crude was up 0.4% at $92.36 early on.
Monday is set to be a relatively quiet day in terms of economic data, with no major releases expected other than the IFO business confidence survey in Germany, with the business climate and current assessment sub-indices expected to weaken and the expectations sub-index forecast to rise.
In UK company news, British insurer Aviva on Monday said it had bought AIG's UK protection business for £460m. AIG Life UK provides a full suite of individual and group protection products, with 1.3 million individual protection customers and 1.4 million group protection members, Aviva said. Aviva's boss Amanda Blanc said the deal "brings significant strategic and financial benefits" to the company. "It strengthens our prospects in the highly attractive UK protection market and continues our progress in repositioning the group towards capital-light growth."
GSK announced the approval of its Arexvy vaccine by Japan's Ministry of Health, Labour and Welfare on Monday for the prevention of RSV disease in adults aged 60 and above, marking the first RSV vaccine for this age group in Japan. The vaccine, which showed an efficacy of 82.6% in phase three trials, aims to combat the virus that results in about 63,000 hospitalisations and 4,500 deaths annually in older adults in Japan. It added to previous authorisations in the US, Europe, the UK, and Canada.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.